An increasing number of mutated genes have been implicated in HCC occurrence and development, including mammalian target of rapamycin, vascular endothelial growth factor (VEGF), and tumor protein (TP)53 (2, 3). This evidence concerns the gene VEGFA and hepatocellular carcinoma.